|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Innovative Spinal Technologies Inc. Raises $39 Million In Private Equity, Led By OrbiMed Advisors, MPM Capital, And JPMorgan Partners
10/19/2005 5:09:04 PM
BOSTON--(BUSINESS WIRE)--Aug. 2, 2005--Innovative Spinal Technologies, Inc. (IST), a privately held medical technology company focused on developing the world's most advanced minimally invasive treatments for spinal disorders, announced today that it closed a $39 million Series B financing. The funding includes a team of investors led by OrbiMed Advisors, MPM Capital, and JPMorgan Partners. The financing will be used to expand IST's world-class team and to accelerate the launch of its next-generation spinal devices.
"This financing represents the next significant step towards our goal of becoming a leading developer of spinal products," said Scott Schorer, IST's President and Chief Executive Officer. "We can now focus our efforts on rapidly addressing real needs of clinicians and patients."
|
|
|
|
|
|
|
|
|
|
|